4//SEC Filing
Panzara Michael A. 4
Accession 0000899243-22-000668
CIK 0001631574other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:18 PM ET
Size
5.7 KB
Accession
0000899243-22-000668
Insider Transaction Report
Form 4
Panzara Michael A.
Franchise Lead, Neurology
Transactions
- Award
Share Option (right to buy)
2022-01-01+200,000→ 200,000 totalExercise: $3.14Exp: 2032-01-01→ Ordinary Shares (200,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001679039
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:18 PM ET
- Size
- 5.7 KB